secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0001493152-24-034014
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Apparatus Regenerative Technology appoints StellarS Capital CEO Mao Zhang to board
--------------------------------------------------------------------------------

- Mao Zhang, Founder & CEO of multi-billion-dollar alternative asset manager StellarS Capital, appointed as independent Class I director effective Aug 26, 2024.
- Mr. Zhang will receive $25,000 stock option grant vesting quarterly over one year; standard non-employee director compensation ($20k cash + $25k options annually).
- Mr. Zhang has over 15 years financial markets experience; previously led Magnetar Capital's Asian business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000149315224034014/0001493152-24-034014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000149315224034014/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-034014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer